Entropy Technologies LP Purchases Shares of 4,199 National Health Investors, Inc. $NHI

Key Points

• Entropy Technologies LP has purchased a new stake in National Health Investors, Inc. (NYSE:NHI) worth approximately $310,000, acquiring 4,199 shares in the 1st quarter.
• Analysts have recently upgraded their ratings for NHI, with Truist Financial raising their price target from $77.00 to $81.00 and maintaining a "buy" recommendation.
• National Health Investors plans to increase its quarterly dividend from $0.90 to $0.92 per share, highlighting a positive change amidst a dividend yield of 4.9%.

Entropy Technologies LP acquired a new stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 4,199 shares of the real estate investment trust's stock, valued at approximately $310,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its stake in shares of National Health Investors by 15.8% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust's stock worth $268,000 after acquiring an additional 495 shares during the period. Bank of New York Mellon Corp grew its stake in shares of National Health Investors by 5.6% in the first quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust's stock worth $43,494,000 after acquiring an additional 31,451 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in shares of National Health Investors by 11.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust's stock worth $267,000 after acquiring an additional 357 shares during the period. SG Americas Securities LLC bought a new stake in shares of National Health Investors in the first quarter worth approximately $808,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in shares of National Health Investors by 3.3% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust's stock worth $35,372,000 after acquiring an additional 15,497 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Price Performance

Shares of NHI stock traded up $0.57 during mid-day trading on Tuesday, hitting $75.46. The company had a trading volume of 34,803 shares, compared to its average volume of 247,743. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $86.13. The stock's 50 day moving average price is $71.61 and its 200-day moving average price is $72.34. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. The company has a market capitalization of $3.58 billion, a P/E ratio of 24.10, a P/E/G ratio of 3.75 and a beta of 0.73.

National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, topping the consensus estimate of $1.16 by $0.06. The firm had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.18 earnings per share. Equities research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.92 dividend. The ex-dividend date is Tuesday, September 30th. This is a boost from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.9%. National Health Investors's dividend payout ratio (DPR) is currently 117.57%.

Wall Street Analysts Forecast Growth

NHI has been the subject of several recent research reports. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research report on Thursday, July 10th. Finally, Truist Financial boosted their target price on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, National Health Investors currently has an average rating of "Buy" and an average price target of $85.40.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.